Innopran Xl
NDC Package 24090-451-77

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Innopran Xl is a medication a beta blocker used to treat high blood pressure. Marketed by Akrimax Pharmaceuticals, Llc, this product is identified by NDC 24090-451 and is authorized under FDA application NDA021438.

Identification & Billing

NDC Package Code
24090-451-77
Package Description
7 CAPSULE, EXTENDED RELEASE in 1 BOTTLE
Product Code
11-Digit Billing Format
24090045177

Clinical Specifications

Proprietary Name
Innopran Xl
Dosage Form
-
Usage Information
This medication is a beta blocker used to treat high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks and kidney problems. This drug works by blocking the action of certain natural chemicals in your body (such as epinephrine) that affect the heart and blood vessels. This results in a lowering of heart rate, blood pressure, and strain on the heart.

Regulatory & Marketing

Labeler Name
Akrimax Pharmaceuticals, Llc
FDA Application #
NDA021438
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
06-01-2013
End Marketing Date
08-31-2019
Listing Expiration
08-31-2019
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (24090-451). Click a package code to view its specific billing and regulatory data.

30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE
100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 24090-451-77 identifies a specific commercial package of 7 capsule, extended release in 1 bottle of Innopran Xl, labeled by Akrimax Pharmaceuticals, Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Akrimax Pharmaceuticals, Llc on June 01, 2013. The current certification is valid through August 31, 2019.

What are the primary indications for this medication?

This medication is a beta blocker used to treat high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks and kidney problems. This drug works by blocking the action of certain natural chemicals in your body (such as epinephrine) that affect the heart and blood vessels. This results in a lowering of heart rate, blood pressure, and strain on the heart.

How is this Akrimax Pharmaceuticals, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 24090045177. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
24090-451-77
11-Digit CMS (5-4-2)
24090-0451-77

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.